Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1Phase 2 1

Status

Terminated 3Completed 3Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Rectal Neoplasms 1Pelvic Neoplasms 1Colonic Polyps 1Colonic Neoplasms 1Chylous Ascites 1Abdominal Neoplasms 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Iohexol × Clear all
NCT06820320 2026-03-06

Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Completed
42 enrolled
Gynecologic

Abdominal Neoplasms, Chylous Ascites, Pelvic Neoplasms

NCT00576563 2016-04-21

Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer

Maastricht Radiation Oncology

Phase NA Completed
103 enrolled
Gastrointestinal

Rectal Neoplasms

NCT01200303 2015-08-05

ncCTC

Massachusetts General Hospital

Phase 2/3 Completed
605 enrolled
Gastrointestinal

Colonic Neoplasms, Colonic Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡